|
2025
|
G/S
|
Cells for scientific, laboratory or medical research. Cells for medical or clinical use; Pharmace... |
|
|
G/S
|
Pharmaceutical preparations in the field of gene therapy for the prevention and treatment of card... |
|
|
G/S
|
Pharmaceutical preparations in the field of cell and gene therapies for the prevention and treatm... |
|
2024
|
Invention
|
Compositions and methods for enhanced payload regulation using nuclear factor of activated t cell... |
|
|
G/S
|
Cells for scientific, laboratory or medical research Cells for medical or clinical use; Pharmaceu... |
|
|
Invention
|
Dhfr tunable protein regulation.
The present invention is related to compositions and methods fo... |
|
2023
|
Invention
|
Administration of tumor infiltrating lymphocytes with membrane bound interleukin 15 to treat canc... |
|
|
G/S
|
Pharmaceutical preparations in the fields of cell therapy, gene therapy, oncology, immunotherapy,... |
|
|
G/S
|
custom manufacture of cells for medical or clinical use for others; custom manufacture of pharmac... |
|
|
Invention
|
Compact drug responsive domains for regulation of function/abundance and delivery of polypeptide ... |
|
|
Invention
|
Methods for identifying and using allogeneic tumor infiltrating lymphocytes to treat cancer.
Pro... |
|
|
Invention
|
Methods for identifying and using allogeneic tumor infiltrating lymphocytes to treat cancer. Prov... |
|
2022
|
Invention
|
Compositions and systems for regulation of function/abundance and delivery of polypeptide payload... |
|
|
Invention
|
Regulated biocircuit systems.
The present invention provides regulatable biocircuit systems. Suc... |
|
|
Invention
|
Pde5 compositions and methods for immunotherapy. The present invention relates to compositions an... |
|
|
Invention
|
Tumor-infiltrating lymphocytes with membrane bound interleukin 15 and uses thereof.
Provided her... |
|
|
Invention
|
Compositions and methods for expansion of t cells and tumor infiltrating lymphocytes.
The presen... |
|
|
Invention
|
Tumor-infiltrating lymphocytes with membrane bound interleukin 15 and uses thereof. Provided here... |
|
|
Invention
|
Tumor-infiltrating lymphocytes with membrane bound interleukin 15 and uses thereof. in vitro rapi... |
|
|
Invention
|
Compositions and methods for expansion of t cells and tumor infiltrating lymphocytes. The present... |
|
|
Invention
|
Compositions and methods for expansion of t cells and tumor infiltrating lymphocytes. in vitroin ... |
|
2021
|
Invention
|
Dhfr tunable protein regulation. The present invention is related to compositions and methods for... |
|
|
Invention
|
Compositions and methods for tunable regulation of cas nucleases.
The present disclosure provide... |
|
|
G/S
|
Cells for scientific, laboratory or medical research. Cells for medical or clinical use; pharmace... |
|
|
G/S
|
Cells in the nature of biological tissue cultures for scientific, laboratory and medical research... |
|
|
Invention
|
Compositions and methods for expression of t-cell receptors with small molecule-regulated cd40l i... |
|
|
Invention
|
Compositions and methods for expression of anti-bcma chimeric antigen receptors with small molecu... |
|
|
Invention
|
Compositions and methods for tunable regulation of cas nucleases. The present disclosure provides... |
|
|
G/S
|
Custom manufacture of cells for medical or clinical use for others; Custom manufacture of pharmac... |
|
|
Invention
|
Compositions and methods for tunable regulation of transcription.
The present disclosure provide... |
|
|
Invention
|
Compositions and methods for tunable regulation of transcription. The present disclosure provides... |
|
2020
|
Invention
|
Ca2-il15 fusion proteins for tunable regulation.
The present disclosure provides drug responsive... |
|
|
Invention
|
Ca2 compositions and methods for tunable regulation. The present disclosure provides drug respons... |
|
|
Invention
|
Ca2-il15 fusion proteins for tunable regulation. The present disclosure provides drug responsive ... |
|
|
Invention
|
Compositions and methods for dhfr tunable protein regulation.
The present disclosure is related ... |
|
|
Invention
|
Compositions and methods for dhfr tunable protein regulation. The present disclosure is related t... |
|
|
Invention
|
Ca2 compositions and methods for tunable regulation. The present disclosure provides regulatable ... |
|
|
Invention
|
Ca2 compositions and methods for tunable regulation.
The present disclosure provides regulatable... |
|
|
Invention
|
Cd40l compositions and methods for tunable regulation.
The present disclosure provides regulatab... |
|
|
Invention
|
Human carbonic anhydrase 2 compositions and methods for tunable regulation. The present disclosur... |
|
|
Invention
|
Cd40l compositions and methods for tunable regulation. The present disclosure provides regulatabl... |
|
2019
|
Invention
|
Membrane bound il12 compositions and methods for tunable regulation. The present disclosure provi... |
|
|
Invention
|
Er tunable protein regulation.
The present disclosure is related to compositions and methods for... |
|
|
Invention
|
Tandem cd19 car-based compositions and methods for immunotherapy.
The present invention provides... |
|
|
Invention
|
Tandem cd19 car-based compositions and methods for immunotherapy. The present invention provides ... |
|
|
G/S
|
Pharmaceutical, medical, and scientific research and development services in the fields of cell t... |
|
|
G/S
|
Pharmaceutical research and development in the field of cell and gene therapies; pharmaceutical r... |
|
|
Invention
|
Pde5 derived regulatory constructs and methods of use in immunotherapy.
The present disclosure r... |
|
2016
|
G/S
|
Pharmaceutical research and development in the field of gene therapy |
